A minimally invasive biosensor platform designed to detect and monitor micronutrient levels in biofluids. By integrating advanced biorecognition elements with novel signal transduction, it enables real-time monitoring, supporting early diagnosis and personalized interventions.
The minimally invasive biosensor platform offers a groundbreaking solution for accurately detecting and monitoring micronutrient levels in human biofluids, such as blood and interstitial fluid. By leveraging advanced biorecognition elements and innovative signal transduction techniques, this platform enables real-time monitoring of micronutrient status. This advancement supports early diagnosis of deficiencies and facilitates personalized nutrition and medical interventions, addressing a critical gap in health management by providing rapid, accessible diagnostics.
Key features:
The biosensor platform is at Technology Readiness Level 4, indicating that it has been validated in a laboratory setting. The next steps include optimizing the design for sensitivity and specificity, integrating into a portable system, and validating its performance in simulated clinical environments.
UT offers a partnership model that reduces risk, accelerates time-to-value, and supports long-term growth strategies for industry—providing an attractive platform for companies seeking to formalize collaboration and establish a long-term presence in the East Tennessee region. By aligning institutional investment with regional and national priorities, UT provides a stable and effective platform for industry collaboration, technology deployment, and sustained economic impact.